Nanostics

Edmonton, Canada

Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.

Jun 2025

Grant

Top Investors

University of AlbertaVA AngelsCanadian Biotechnology Innovation and Commercialization Initiative

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Nanostics's investors?

Nanostics's investors include University of Alberta, VA Angels, Canadian Biotechnology Innovation and Commercialization Initiative.

Where is Nanostics headquartered?

Nanostics is headquartered in Edmonton, Canada.

What does Nanostics do?

Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.

What stage is Nanostics at?

Nanostics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 26, 2025.

MLA

"Nanostics — Funding & Investors." VCBacked, June 26, 2025, https://www.vcbacked.co/company/nanostics. Accessed July 1, 2026.

APA

VCBacked. (2025). Nanostics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nanostics

Wikipedia (cite web)

{{cite web |title=Nanostics — Funding & Investors |url=https://www.vcbacked.co/company/nanostics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 26, 2025.